Prescription drug · NDA AUTHORIZED GENERIC
Doxazosin mesylate NDC 71610-965
Doxazosin mesylate 4 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-965-53 | 7161009655371610096553 | 60 TABLET in 1 BOTTLE (71610-965-53)Marketed from Nov 21, 2025 | |
| 71610-965-60 | 7161009656071610096560 | 90 TABLET in 1 BOTTLE (71610-965-60)Marketed from Nov 21, 2025 | |
| 71610-965-70 | 7161009657071610096570 | 120 TABLET in 1 BOTTLE (71610-965-70)Marketed from Nov 21, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxazosin mesylate
- Generic name (nonproprietary)
- doxazosin mesylate
- Active ingredients
- Doxazosin mesylate — 4 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 019668
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 71610-965_445e0469-117c-0ed5-e063-6394a90abe40SPL ID 445e0469-117c-0ed5-e063-6394a90abe40SPL set ID 445dc831-1960-4b25-e063-6294a90a6efdRxCUI 197627UNII 86P6PQK0MU
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610096553followed by a unit qualifier and the quantityPackage 71610-0965-53. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Doxazosin is an alpha 1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH) ( 1.1 ) Treatment of Hypertension ( 1.2 ) 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablet is indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablet is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure shoul…
Excerpt only. Read the full label for complete information.
About NDC 71610-965
- What is NDC 71610-965?
- 71610-965 is the product NDC for Doxazosin mesylate, Doxazosin mesylate 4 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Doxazosin mesylate.
- What is the active ingredient?
- Doxazosin mesylate.
- Who is the labeler?
- Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Doxazosin mesylate?
- 13 other product NDCs are listed under this name. See all Doxazosin mesylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Doxazosin mesylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Doxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1391 | 59762-1391-07 |
| Doxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1390 | 59762-1390-07 |
| Doxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1388 | 59762-1388-07 |
| Doxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1389 | — |
| Doxazosin Mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-351 | 29300-0351-0129300-0351-1029300-0351-13 |
| Doxazosin Mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-352 | 29300-0352-0129300-0352-1029300-0352-13 |
| Doxazosin Mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-353 | 29300-0353-0129300-0353-1029300-0353-13 |
| Doxazosin Mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-354 | 29300-0354-0129300-0354-1029300-0354-13 |
| Doxazosin Mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Unichem Laboratories Limited, India | 53747-352 | 53747-0352-0153747-0352-1053747-0352-13 |
| Doxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Chartwell RX, LLC | 62135-051 | 62135-0051-90 |
Other NDCs under NDA 019668
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Carduradoxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | ROERIG | 0049-2716 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-927 |
| Carduradoxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | ROERIG | 0049-2512 |
| Carduradoxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | ROERIG | 0049-2614 |
| Doxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1390 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-628 |
| Doxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1388 |
| Doxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1389 |
| Doxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-1391 |
| Carduradoxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Viatris Specialty LLC | 58151-075 |
| Doxazosin | Doxazosin mesylate 2 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-2420 |
| Carduradoxazosin | Doxazosin mesylate 1 mg/1 | TabletOral | Viatris Specialty LLC | 58151-074 |
| Doxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-2440 |
| Carduradoxazosin | Doxazosin mesylate 4 mg/1 | TabletOral | Viatris Specialty LLC | 58151-076 |
| Doxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Mylan Pharmaceuticals Inc. | 59762-2480 |
| Carduradoxazosin | Doxazosin mesylate 8 mg/1 | TabletOral | Viatris Specialty LLC | 58151-077 |